There will be a price to pay for making vaccines too expensive

Few developing countries will be interested, for example, in the vaccine produced by Moderna Inc., which requires the sort of super-cooled storage facilities they would struggle to build.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mcch36
via IFTTT